Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Clinical trial NCT02642159 · COMPLETED
Trial details
- NCT number
- NCT02642159
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2017-03-22
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.